NEOGENOMICS INC
Company Information
Industry Services-Testing Laboratories
SIC Code 8734
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation NV
Business Address 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Mailing Address 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Phone 2397680600
Fiscal Year End 1231
EIN 742897368
Financial Overview
FY2024
$1.68B
Total Assets
$739.69M
Total Liabilities
$902.34M
Stockholders' Equity
$367.01M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 3 Initial insider ownership report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
Insider Trading
SELL 2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8734)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.